Definitive Contract 75N95026C00002
- Not listed
- The National Institute on Drug Abuse (NIDA) has awarded a definitive cost-plus-no-fee contract valued at $30.3M to the University of Maryland, Baltimore to establish and operate the NIH NeuroBioBank Brain and Tissue Repository (NBB), a collection site that will acquire, process, store, curate, preserve, and distribute central nervous system (CNS) and related tissue samples for neurological, psychiatric, and neurodevelopmental disorder research. The contract, which carries no set-aside...
- The National Institute on Drug Abuse (NIDA) awarded a definitive cost-no-fee contract to the University of Miami's Office of Research Administration in the School of Medicine to establish and operate the NIH Neurobiobank Brain and Tissue Repository (NBB) collection site in South Miami, Florida. Under this $26.6 million contract through October 31, 2030, the University of Miami will actively acquire, receive, process, store, curate, preserve, and distribute central nervous system (CNS) and...
- The National Institute on Drug Abuse (NIDA) awarded a $18.5M cost-plus-no-fee definitive contract to the Icahn School of Medicine at Mount Sinai to establish and operate the NIH NeuroBank Brain and Tissue Repository, a collection site for acquiring, processing, storing, curating, and distributing central nervous system and related tissue samples for neuroscience research. The contract, which commenced November 1, 2025, and runs through October 31, 2030, was awarded without set-aside...
- This federal contract was awarded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), to the University of Miami to establish a collection site (the NIH Brain and Tissue Repository) that will actively acquire, receive, store, curate, preserve, and distribute central nervous system and related biological specimens for research on neurological, psychiatric, and neurodevelopmental disorders. The $25,542,514.53 contract is for a definitive, cost-no-fee...
- The National Institute on Drug Abuse awarded a $19.9M definitive cost-no-fee contract to the University of Pittsburgh to establish and operate the NIH NeuroRioBank Brain and Tissue Repository, a collection site that will actively acquire, process, store, curate, preserve, and distribute central nervous system and related tissues for research purposes. The contract, which runs through October 31, 2030, supports the broader NIH initiative to increase availability of post-mortem human brain...
- This federal contract was awarded by the National Institutes of Health (NIH) to the University of Maryland, Baltimore (UMB) to administer the NIH NeuroBioBank and Tissue Repository. The purpose is to increase the availability of human brain tissue samples for research on neurological, psychiatric, and neurodevelopmental disorders. The contract has a ceiling value of $23,683,813.78 and was awarded on a cost-no-fee basis with an ultimate completion date of October 31, 2025. It is not a set-aside...
- This is a federal contract award from the National Institute on Drug Abuse (NIDA), a civilian agency within the National Institutes of Health (NIH), to the Greater Los Angeles Veterans Research And Education Foundation (GLAVREF), a non-profit organization. The contract, valued at $12,774,018.84, is for the NIH NEUROBIOBANK BRAIN AND TISSUE REPOSITORY and has a period of performance from September 1, 2019 to August 31, 2020, with a potential ultimate completion date of October 31, 2025. The...
- The National Institute on Drug Abuse awarded a definitive cost-no-fee contract valued at approximately $34.5 million to The McLean Hospital Corporation to establish and operate the NIH NeuroBank Brain and Tissue Repository collection site in Belmont, Massachusetts. Under this five-year contract extending through October 31, 2030, McLean Hospital will actively acquire, receive, process, store, curate, preserve, and distribute central nervous system (CNS) and related tissues for neurological,...
- This is a $15,570,163.30 definitive contract awarded by the National Institute on Drug Abuse (part of the National Institutes of Health) to the Icahn School of Medicine at Mount Sinai (ISMMS) to establish a collection site for the NIH Brain and Tissue Repository (NBTR). The purpose is to acquire, receive, process, store, curate, preserve, and distribute central nervous system and related biological samples to support research on neurological, psychiatric, and neurodevelopmental disorders. The...
- This is a definitive contract awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to the University of Pittsburgh to establish and operate the NEUROBIOBANK Brain and Tissue Repository. The contract is valued at $18,517,576.37 and has an ultimate completion date of October 31, 2025. The purpose of the contract is to administratively de-obligate unexpended and expiring fiscal year 2020 funding in preparation for the September 30, 2025...
The National Institute on Drug Abuse awarded a $13.1M cost-plus-no-fee definitive contract to The University of Iowa to establish and operate the NIH NeuroBank Brain and Tissue Repository (NBB), a collection site for acquiring, processing, storing, curating, preserving, and distributing central nervous system tissues and related materials for neurological, psychiatric, and neurodevelopmental disorder research. The contract, which commenced November 1, 2025 and extends through October 31, 2030, was awarded under full and open competition through solicitation 75N95024R00124. The University of Iowa will be responsible for acquiring brain tissue from deceased donors with diverse neurological, neuropsychiatric, and neurodevelopmental conditions as well as control subjects, ensuring demographic diversity across race, ethnicity, and age. The contractor must maintain detailed inventory documentation through the NIH NeuroBank Portal and adhere to tissue-sharing guidelines established by the National Institutes of Health. Under the contract's five-year performance period, the University of Iowa is expected to acquire a minimum of 70 donors annually, with potential processing capacity up to 150 unique donors per year, supporting the broader initiative to increase tissue availability for federally-funded research. This award was coordinated with multiple NIH institutes and centers, including the National Institute of Mental Health, National Institute of Child Health and Human Development, National Institute of Neurological Diseases and Stroke, and National Institute on Aging, as part of the Blueprint for Neuroscience program. No set-aside designation applies to this contract, and the award reflects the university's established capability in federal research partnerships and biomedical services delivery. The contract is classified under NAICS code 541714 (Research and Development in Biotechnology).
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 10/31/25 |